{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T18:45:19Z","timestamp":1789670719700,"version":"4.0.1"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,5]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Invasive group A streptococcal disease is a severe infection with a high case fatality rate, estimated to cause more than 150,000 deaths per year worldwide. The clinical presentation of this infection is variable, and early diagnosis can be challenging. There are few data on its short- and longer-term outcomes, especially in children. The aim of this study was to assess the clinical presentation, management and short- and longer-term outcomes of invasive group A streptococcal disease in children in Australia.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>We undertook a prospective surveillance study of children with laboratory-confirmed invasive group A streptococcus disease admitted to 7 sentinel tertiary and quaternary pediatric hospitals in Australia between July 2016 and June 2018. We collected demographic and clinical data and contacted patients 6 months after discharge to assess longer-term outcomes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>We enrolled 181 children, 7 days to 16 years of age. The principal site of invasive infection was blood (126 children, 69.6%), and the most frequent clinical presentation was pneumonia in 46 children (25.4%). Twenty-six children developed streptococcal toxic shock syndrome (14.4%), and 74 had severe disease (40.9%), including 71 admitted to the intensive care unit. Five children died (2.8%). At discharge and 6 months, 29.3% and 15.2% of the children had persisting health problems, respectively.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Invasive group A streptococcal infection in Australian children is frequently severe and has a high long-term morbidity burden, highlighting the need for strengthened clinical care pathways, epidemiologic surveillance and prevention strategies.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/inf.0000000000002596","type":"journal-article","created":{"date-parts":[[2020,2,21]],"date-time":"2020-02-21T19:25:47Z","timestamp":1582313147000},"page":"379-384","source":"Crossref","is-referenced-by-count":17,"title":["Clinical Description and Outcomes of Australian Children With Invasive Group A Streptococcal Disease"],"prefix":"10.1097","volume":"39","author":[{"given":"Elise","family":"Thielemans","sequence":"first","affiliation":[{"name":"Tropical Diseases Research Group, Murdoch Children\u2019s Research Institute, Royal Children\u2019s Hospital, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Oliver","sequence":"additional","affiliation":[{"name":"Paediatric Department, Universit\u00e9 Libre de Bruxelles, Bruxelles, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alissa","family":"McMinn","sequence":"additional","affiliation":[{"name":"Paediatric Department, Universit\u00e9 Libre de Bruxelles, Bruxelles, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciara","family":"Baker","sequence":"additional","affiliation":[{"name":"Paediatric Department, Universit\u00e9 Libre de Bruxelles, Bruxelles, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip N.","family":"Britton","sequence":"additional","affiliation":[{"name":"Westmead Children\u2019s Hospital and Sydney Medical School, University of Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Clark","sequence":"additional","affiliation":[{"name":"Queensland Children\u2019s Hospital, Queensland and School of Clinical Medicine, University of Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Marshall","sequence":"additional","affiliation":[{"name":"Women\u2019s and Children\u2019s Hospital and Robinson Research Institute, The University of Adelaide, South Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher C.","family":"Blyth","sequence":"additional","affiliation":[{"name":"Telethon Kids Institute, University of Western Australia and Perth Children\u2019s Hospital, Western Australia, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Francis","sequence":"additional","affiliation":[{"name":"Royal Darwin Hospital, Northern Territory, Australia and Menzies School of Health Research, Northern Territory, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jim","family":"Buttery","sequence":"additional","affiliation":[{"name":"Monash Health, Monash University, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre R.","family":"Smeesters","sequence":"additional","affiliation":[{"name":"Hopital Universitaire des Enfants Reine Fabiola, Bruxelles, Belgium."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel","family":"Crawford","sequence":"additional","affiliation":[{"name":"Paediatric Department, Universit\u00e9 Libre de Bruxelles, Bruxelles, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew C.","family":"Steer","sequence":"additional","affiliation":[{"name":"Paediatric Department, Universit\u00e9 Libre de Bruxelles, Bruxelles, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230912","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1128\/CMR.00101-13","article-title":"Disease manifestations and pathogenic mechanisms of Group A Streptococcus.","volume":"27","author":"Walker","year":"2014","journal-title":"Clin Microbiol Rev"},{"key":"R2-20230912","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1093\/cid\/ciw248","article-title":"Epidemiology of invasive group A Streptococcal infections in the United States, 2005-2012.","volume":"63","author":"Nelson","year":"2016","journal-title":"Clin Infect Dis"},{"key":"R3-20230912","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.2165\/11634180-000000000-00000","article-title":"Invasive group a streptococcal disease: epidemiology, pathogenesis and management.","volume":"72","author":"Steer","year":"2012","journal-title":"Drugs"},{"key":"R4-20230912","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1128\/JCM.00422-08","article-title":"Epidemiology of severe Streptococcus pyogenes disease in Europe.","volume":"46","author":"Lamagni","year":"2008","journal-title":"J Clin Microbiol"},{"key":"R5-20230912","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S1473-3099(05)70267-X","article-title":"The global burden of group A streptococcal diseases.","volume":"5","author":"Carapetis","year":"2005","journal-title":"Lancet Infect Dis"},{"key":"R6-20230912","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/00006454-199401000-00011","article-title":"Apparent lower rates of streptococcal toxic shock syndrome and lower mortality in children with invasive group A streptococcal infections compared with adults.","volume":"13","author":"Davies","year":"1994","journal-title":"Pediatr Infect Dis J"},{"key":"R7-20230912","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1017\/S0950268813001386","article-title":"Differences in the epidemiology between paediatric and adult invasive Streptococcus pyogenes infections.","volume":"142","author":"Zachariadou","year":"2014","journal-title":"Epidemiol Infect"},{"key":"R8-20230912","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1136\/archdischild-2013-304741","article-title":"Toxic shock syndrome surveillance in UK children.","volume":"99","author":"Adalat","year":"2014","journal-title":"Arch Dis Child"},{"key":"R9-20230912","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1136\/archdischild-2015-310121","article-title":"Toxic shock syndrome in Australian children.","volume":"101","author":"Chen","year":"2016","journal-title":"Arch Dis Child"},{"key":"R10-20230912","doi-asserted-by":"crossref","first-page":"360","DOI":"10.3389\/fped.2018.00360","article-title":"Similarities and differences between Staphylococcal and Streptococcal toxic shock syndromes in children: results from a 30-case cohort.","volume":"6","author":"Javouhey","year":"2018","journal-title":"Front Pediatr"},{"key":"R11-20230912","first-page":"367","article-title":"Group A streptococcal bacteremia: outcome and prognostic factors.","volume":"19","author":"Vallalta Morales","year":"2006","journal-title":"Rev Esp Quimioter"},{"key":"R12-20230912","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1086\/521264","article-title":"The epidemiology of invasive group A streptococcal infection and potential vaccine implications: United States, 2000-2004.","volume":"45","author":"O\u2019Loughlin","year":"2007","journal-title":"Clin Infect Dis"},{"key":"R13-20230912","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1007\/s100960050349","article-title":"Group A streptococcal meningitis in the antibiotic era.","volume":"18","author":"Barald\u00e9s","year":"1999","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R14-20230912","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3201\/eid1402.070888","article-title":"Severe Streptococcus pyogenes Infections, United Kingdom, 2003\u20132004.","volume":"14","author":"Lamagni","year":"2008","journal-title":"Emerg Infect Dis"},{"key":"R15-20230912","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/INF.0b013e31826fd4af","article-title":"Group A streptococcus meningitis in children.","volume":"32","author":"de Almeida Torres","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"R16-20230912","doi-asserted-by":"crossref","DOI":"10.1136\/bcr.10.2011.4896.corr1","article-title":"Group-A-streptococcal meningitis in a 7-year-old child \u2013 a rare pathogen in a non-immune compromised patient.","volume":"2011","author":"van Zitteren","year":"2011","journal-title":"BMJ Case Rep"},{"key":"R17-20230912","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s15010-002-1182-6","article-title":"Invasive group A streptococcal infections in a large tertiary center: epidemiology, characteristics and outcome.","volume":"30","author":"Ben-Abraham","year":"2002","journal-title":"Infection"},{"key":"R18-20230912","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1093\/infdis\/jit594","article-title":"Effects of selective and nonselective nonsteroidal anti-inflammatory drugs on antibiotic efficacy of experimental group A streptococcal myonecrosis.","volume":"209","author":"Hamilton","year":"2014","journal-title":"J Infect Dis"},{"key":"R19-20230912","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/QCO.0000000000000160","article-title":"The roles of injury and nonsteroidal anti-inflammatory drugs in the development and outcomes of severe group A streptococcal soft tissue infections.","volume":"28","author":"Bryant","year":"2015","journal-title":"Curr Opin Infect Dis"},{"key":"R20-20230912","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1469-0691.2005.01311.x","article-title":"Group A streptococcus bacteraemia: comparison of adults and children in a single medical centre.","volume":"12","author":"Megged","year":"2006","journal-title":"Clin Microbiol Infect"},{"key":"R21-20230912","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/jpc.12282","article-title":"Paediatric active enhanced disease surveillance: a new surveillance system for Australia.","volume":"49","author":"Zurynski","year":"2013","journal-title":"J Paediatr Child Health"},{"key":"R22-20230912","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2013a metadata-driven methodology and workflow process for providing translational research informatics support.","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"R24-20230912","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1186\/s12889-019-8085-2","article-title":"Invasive group A Streptococcus disease in Australian children: 2016 to 2018 - a descriptive cohort study.","volume":"19","author":"Oliver","year":"2019","journal-title":"BMC Public Health"},{"key":"R25-20230912","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/INF.0000000000000043","article-title":"The clinical burden and predictors of sequelae following invasive meningococcal disease in Australian children.","volume":"33","author":"Wang","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"R26-20230912","first-page":"199","article-title":"Multicenter study on invasive Streptococcus pyogenes infections in children in Argentina.","volume":"114","author":"Cancellara","year":"2016","journal-title":"Arch Argent Pediatr"},{"key":"R27-20230912","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1586\/eri.13.42","article-title":"The burden and impact of severe and long-term sequelae of meningococcal disease.","volume":"11","author":"Vyse","year":"2013","journal-title":"Expert Rev Anti Infect Ther"},{"key":"R28-20230912","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/pch\/15.5.295","article-title":"Invasive group A streptococcal disease: Management and chemoprophylaxis.","volume":"15","author":"Allen","year":"2010","journal-title":"Paediatr Child Health"},{"key":"R29-20230912","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1086\/606048","article-title":"Intravenous immunoglobulin in children with streptococcal toxic shock syndrome.","volume":"49","author":"Shah","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"suppl 1","key":"R30-20230912","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1016\/j.jinf.2014.08.005","article-title":"Management of invasive group A streptococcal infections.","volume":"69","author":"Waddington","year":"2014","journal-title":"J Infect"},{"key":"R31-20230912","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1093\/cid\/ciu304","article-title":"Effectiveness of clindamycin and intravenous immunoglobulin, and risk of disease in contacts, in invasive group a streptococcal infections.","volume":"59","author":"Carapetis","year":"2014","journal-title":"Clin Infect Dis"},{"key":"R32-20230912","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1086\/515199","article-title":"Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome\u2013a comparative observational study. The Canadian Streptococcal Study Group.","volume":"28","author":"Kaul","year":"1999","journal-title":"Clin Infect Dis"},{"key":"R33-20230912","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1086\/376630","article-title":"Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebo-controlled trial.","volume":"37","author":"Darenberg","year":"2003","journal-title":"Clin Infect Dis"},{"key":"R34-20230912","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1440-1754.2007.01161.x","article-title":"Over-the-counter medication use for childhood fever: a cross-sectional study of Australian parents.","volume":"43","author":"Walsh","year":"2007","journal-title":"J Paediatr Child Health"},{"key":"R35-20230912","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3201\/eid2202.151358","article-title":"Invasive Group A Streptococcus Infection among Children, Rural Kenya.","volume":"22","author":"Seale","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"R36-20230912","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1128\/JCM.06697-11","article-title":"Clinical and microbiologic characteristics of invasive Streptococcus pyogenes infections in north and south India.","volume":"50","author":"Haggar","year":"2012","journal-title":"J Clin Microbiol"},{"key":"R37-20230912","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1055\/s-0038-1677456","article-title":"A cluster of pediatric invasive group a Streptococcus Disease in melbourne, Australia, coinciding with a high-burden influenza season.","volume":"14","author":"Wong","year":"2019","journal-title":"J Pediatr Infect Dis"},{"key":"R38-20230912","doi-asserted-by":"crossref","first-page":"4104","DOI":"10.1128\/JVI.77.7.4104-4112.2003","article-title":"Influenza A virus-infected hosts boost an invasive type of Streptococcus pyogenes infection in mice.","volume":"77","author":"Okamoto","year":"2003","journal-title":"J Virol"},{"key":"R39-20230912","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.4049\/jimmunol.1300014","article-title":"Depletion of alveolar macrophages during influenza infection facilitates bacterial superinfections.","volume":"191","author":"Ghoneim","year":"2013","journal-title":"J Immunol"},{"key":"R40-20230912","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3389\/fmicb.2016.00342","article-title":"The association between invasive Group A Streptococcal diseases and viral respiratory tract infections.","volume":"7","author":"Herrera","year":"2016","journal-title":"Front Microbiol"},{"key":"R41-20230912","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1093\/jpids\/pix099","article-title":"Prospective Surveillance of Pediatric Invasive Group A Streptococcus Infection.","volume":"8","author":"Ching","year":"2019","journal-title":"J Pediatr Infect Dis Soc"},{"key":"R42-20230912","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.annemergmed.2014.10.022","article-title":"Repeated emergency department visits among children admitted with meningitis or septicemia: a population-based study.","volume":"65","author":"Vaillancourt","year":"2015","journal-title":"Ann Emerg Med"},{"key":"R43-20230912","doi-asserted-by":"crossref","first-page":"30532","DOI":"10.2807\/1560-7917.ES.2017.22.19.30532","article-title":"Household transmission of invasive group A Streptococcus infections in England: a population-based study, 2009, 2011 to 2013.","volume":"22","author":"Mearkle","year":"2017","journal-title":"Eurosurveillance"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000002596","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T22:56:06Z","timestamp":1694559366000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000002596"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000002596","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]}}}